+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

AI In Oncology Market Size, Share & Trends Analysis Report By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • February 2024
  • Region: Global
  • Grand View Research
  • ID: 5943907
Description Jump to:
The global AI in oncology market size is expected to reach USD 19.17 billion by 2030, registering a CAGR of 28.92% from 2024 to 2030. The market is anticipated to witness significant growth owing to increasing prevalence of cancer among the global population, propelling the need to develop technologically advanced products to diagnose, treat, and analyze cancer. For instance, the International Agency for Research on Cancer (IARC) expects over 20.7 million new cases in 2023. Moreover, AI enables early detection, crucial for lowering mortality, especially through efficient screening programs.

Emerging markets are witnessing a rising prevalence of cancer due to various factors, including lifestyle changes & aging populations. The surge in cancer cases in these markets creates a demand for advanced technologies like AI in oncology to improve early detection, personalized treatment, and overall patient outcomes. For instance, in January 2024, India's first AI-Precision Oncology Centre (POC) was launched at Apollo Cancer Centre in Bengaluru. The POC will utilize the vast possibilities offered by AI to help oncologists, patients, and caregivers achieve the best possible results within a specified time frame.

AI is transforming the field of oncology by integrating vast datasets from multi-omics analyses with the latest developments in deep learning and high-performance computing techniques. AI applications are expanding to include new detection, screening, diagnosis, and classification approaches, cancer genomics characterization, tumor microenvironment analysis, prognostic and predictive biomarkers assessment, and strategies for follow-up and drug discovery. For instance, in October 2022, Model Medicines launched an oncology program focusing on identifying and developing therapeutics against two epigenetic and oncogenic targets, focusing on applications for solid and hematological malignancies.

The major players operating in the market are adopting strategies such as collaborations and partnerships with a major focus on development of newer products to aid in the early diagnosis of cancer, meet rising demand, and enhance research and development pipeline. For instance, in December 2022, AstraZeneca collaborated with Clinithink to launch an AI project for lung cancer. This project aims to detect lung cancer at an early stage to aid in the developing of effective treatment.

Furthermore, in November 2022, Google Health entered into a partnership with iCAD, Inc. for the improvement of breast cancer screening using the company’s artificial intelligence technology. Additionally, a number of public and private organizations are focusing on funding and investment for R&D in AI-based oncology screening products. For instance, in March 2023, Artera received funding of USD 90 million for the launch and distribution of the ArteraAI Prostate Test, the first developed test for predicting therapy in localized prostate cancer.

AI In Oncology Market Report Highlights

  • Based on component type, the software solutions segment is anticipated to grow at the fastest CAGR over the forecast period, owing to increasing adoption of software solutions for a wide number of applications due to the better outcomes offered by this component
  • Based on cancer type, the prostate cancer segment is anticipated to grow at the fastest CAGR over the forecast period in the market with rising prevalence amongst the population. Prostate cancer generally affects 13 out of every 100 men in the U.S., according to the data published by CDC
  • Based on application type, the research and development segment is expected to grow at the lucrative CAGR over the forecast period. This is attributable to the widespread adoption and amalgamation of advanced AI-enabled algorithms in pharmaceutical companies
  • Based on end-use, the hospitals dominated the market and registered the fastest growth owing to growing number of companies collaborating or introducing AI-powered cancer care solutions in hospitals
  • North America dominated the market due to the availability of favorable government initiatives and digital infrastructure to provide digital solutions to patients

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Component outlook
2.2.2. Cancer type outlook
2.2.3. Application outlook
2.2.4. End-use outlook
2.3. Competitive Landscape Snapshot
Chapter 3. AI In Oncology Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing demand for early detection and classification of cancer
3.2.1.1.1.Case study 1
3.2.1.1.2.Case study 2
3.2.1.2. Increasing prevalence of cancer
3.2.1.2.1.Breast
3.2.1.2.2.Barain & CNS
3.2.1.2.3.Kidney
3.2.1.2.4.Non-Hodgkin lymphoma
3.2.1.2.5.Bladder
3.2.1.2.6.Colon & rectum
3.2.1.2.7.Prostate
3.2.1.2.8.Case Study 3
3.2.1.3. Rising adoption of precision medicine
3.2.2. Market Restraint Analysis
3.2.2.1. High procurement and implementation cost
3.2.2.2. Lack of skilled workforce
3.2.2.3. High impact of regulations
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.4. Impact of COVID-19 on AI in Oncology Market
Chapter 4. AI In Oncology Market Segment Analysis, By Component, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Component Segment Dashboard
4.3. Global AI In Oncology Market, by Component, 2018 to 2030
4.4. Software Solution
4.4.1. Software Solution Market, 2018 - 2030 (USD Million)
4.5. Hardware
4.5.1. Hardware Market, 2018 - 2030 (USD Million)
4.6. Services
4.6.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. AI In Oncology Market Segment Analysis, By Cancer Type, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Cancer Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4. Breast Cancer
5.4.1. Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
5.5. Lung Cancer
5.5.1. Lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
5.6. Prostate Cancer
5.6.1. Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
5.7. Colorectal Cancer
5.7.1. Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Million)
5.8. Brain Tumor
5.8.1. Brain tumor market estimates and forecast, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. AI In Oncology Market Segment Analysis, By Application, 2018 - 2030 (USD Million)
6.1. Definition and Scope
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4. Diagnostics (Pathology, Cancer Radiology)
6.4.1. Diagnostics (pathology, cancer radiology) market estimates and forecast, 2018 - 2030 (USD Million)
6.5. Radiation Therapy (Radiotherapy)
6.5.1. Radiation therapy (radiotherapy) market estimates and forecast, 2018 - 2030 (USD Million)
6.6. Research & Development (Drug Design, Development Process, etc.)
6.6.1. Research & development (drug design, development process, etc.) market estimates and forecast, 2018 - 2030 (USD Million)
6.7. Chemotherapy
6.7.1. Chemotherapy market estimates and forecast, 2018 - 2030 (USD Million)
6.8. Immunotherapy
6.8.1. Immunotherapy market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. AI In Oncology Market Segment Analysis, By End-use Type, 2018 - 2030 (USD Million)
7.1. Definitions and Scope
7.2. End-use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4. Hospitals
7.4.1. Hospitals Market, 2018 - 2030 (USD Million)
7.5. Surgical Centers & Medical Institutes
7.5.1. Surgical centers & medical institutes market estimates and forecast, 2018 - 2030 (USD Million)
7.6. Others (Pharmaceutical Companies, Research Institutes & Training Centers)
7.6.1. Others (pharmaceutical companies, research institutes & training centers) market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. AI In Oncology Market Segment Analysis, By Region, By Component, By Cancer Type, By Application, By End-use, 2018 - 2030 (USD Million)
8.1. Definition & Scope
8.2. Regional Market Share Analysis, 2023 & 2030
8.3. Regional Market Dashboard
8.4. Regional Market Snapshot
8.5. SWOT Analysis
8.6. North America
8.6.1. North America Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.6.2. U.S.
8.6.2.1. Key Country Dynamic
8.6.2.2. Regulatory Framework
8.6.2.3. Competitive Insights
8.6.2.4. U.S. Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.6.3. Canada
8.6.3.1. Key Country Dynamic
8.6.3.2. Regulatory Framework
8.6.3.3. Competitive Insights
8.6.3.4. Canada Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.7. Europe
8.7.1. Europe Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.7.2. Germany
8.7.2.1. Key Country Dynamic
8.7.2.2. Regulatory Framework
8.7.2.3. Competitive Insights
8.7.2.4. Germany Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.7.3. UK
8.7.3.1. Key Country Dynamic
8.7.3.2. Regulatory Framework
8.7.3.3. Competitive Insights
8.7.3.4. UK Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.7.4. France
8.7.4.1. Key Country Dynamic
8.7.4.2. Regulatory Framework
8.7.4.3. Competitive Insights
8.7.4.4. France Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.7.5. Italy
8.7.5.1. Key Country Dynamic
8.7.5.2. Regulatory Framework
8.7.5.3. Competitive Insights
8.7.5.4. Italy Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.7.6. Spain
8.7.6.1. Key Country Dynamic
8.7.6.2. Regulatory Framework
8.7.6.3. Competitive Insights
8.7.6.4. Spain Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.7.7. Denmark
8.7.7.1. Key Country Dynamic
8.7.7.2. Regulatory Framework
8.7.7.3. Competitive Insights
8.7.7.4. Denmark Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.7.8. Sweden
8.7.8.1. Key Country Dynamic
8.7.8.2. Regulatory Framework
8.7.8.3. Competitive Insights
8.7.8.4. Sweden Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.7.9. Norway
8.7.9.1. Key Country Dynamic
8.7.9.2. Regulatory Framework
8.7.9.3. Competitive Insights
8.7.9.4. Norway Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.8. Asia Pacific
8.8.1. Asia Pacific Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.8.2. Japan
8.8.2.1. Key Country Dynamic
8.8.2.2. Regulatory Framework
8.8.2.3. Competitive Insights
8.8.2.4. Japan Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.8.3. China
8.8.3.1. Key Country Dynamic
8.8.3.2. Regulatory Framework
8.8.3.3. Competitive Insights
8.8.3.4. China Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.8.4. India
8.8.4.1. Key Country Dynamic
8.8.4.2. Regulatory Framework
8.8.4.3. Competitive Insights
8.8.4.4. India Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.8.5. South Korea
8.8.5.1. Key Country Dynamic
8.8.5.2. Regulatory Framework
8.8.5.3. Competitive Insights
8.8.5.4. South Korea Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.8.6. Australia
8.8.6.1. Key Country Dynamic
8.8.6.2. Regulatory Framework
8.8.6.3. Competitive Insights
8.8.6.4. Australia Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.8.7. Thailand
8.8.7.1. Key Country Dynamic
8.8.7.2. Regulatory Framework
8.8.7.3. Competitive Insights
8.8.7.4. Thailand Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.9. Latin America
8.9.1. Latin America Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.9.2. Brazil
8.9.2.1. Key Country Dynamic
8.9.2.2. Regulatory Framework
8.9.2.3. Competitive Insights
8.9.2.4. Brazil Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.9.3. Mexico
8.9.3.1. Key Country Dynamic
8.9.3.2. Regulatory Framework
8.9.3.3. Competitive Insights
8.9.3.4. Mexico Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.9.4. Argentina
8.9.4.1. Key Country Dynamic
8.9.4.2. Regulatory Framework
8.9.4.3. Competitive Insights
8.9.4.4. Argentina Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.10. MEA
8.10.1. MEA Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.10.2. South Africa
8.10.2.1. Key Country Dynamic
8.10.2.2. Regulatory Framework
8.10.2.3. Competitive Insights
8.10.2.4. South Africa Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.10.3. Saudi Arabia
8.10.3.1. Key Country Dynamic
8.10.3.2. Regulatory Framework
8.10.3.3. Competitive Insights
8.10.3.4. Saudi Arabia Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.10.4. UAE
8.10.4.1. Key Country Dynamic
8.10.4.2. Regulatory Framework
8.10.4.3. Competitive Insights
8.10.4.4. UAE Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
8.10.5. Kuwait
8.10.5.1. Key Country Dynamic
8.10.5.2. Regulatory Framework
8.10.5.3. Competitive Insights
8.10.5.4. Kuwait Healthcare AI in Oncology Market, 2018 - 2030 (USD Million)
Chapter 9. AI In Oncology Market - Competitive Analysis
9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company Categorization
9.3. Company Profiles
9.3.1. Azra AI
9.3.1.1. Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. IBM
9.3.2.1. Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Siemens Healthcare GmbH
9.3.3.1. Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Intel Corporation
9.3.4.1. Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. GE HealthCare
9.3.5.1. Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. NVIDIA Corporation
9.3.6.1. Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Digital Diagnostics Inc.
9.3.7.1. Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. ConcertAI
9.3.8.1. Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Median Technologies
9.3.9.1. Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. PathAI
9.3.10.1. Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global AI in oncology market, by region, 2018 - 2030 (USD Million)
Table 4 Global AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 5 Global AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 6 Global AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 7 Global AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 8 North America AI in oncology market, by region, 2018 - 2030 (USD Million)
Table 9 North America AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 10 North America AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 11 North America AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 12 North America AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 13 U.S. AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 14 U.S. AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 16 U.S. AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 17 Canada AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 18 Canada AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 19 Canada AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 20 Canada AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 21 Europe AI in oncology market, by region, 2018 - 2030 (USD Million)
Table 22 Europe AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 23 Europe AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 24 Europe AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 25 Europe AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 26 Germany AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 27 Germany AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 28 Germany AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 29 Germany AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 30 UK AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 31 UK AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 32 UK AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 33 UK AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 34 France AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 35 France AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 36 France AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 37 France AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 38 Italy AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 39 Italy AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 40 Italy AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 41 Italy AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 42 Spain AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 43 Spain AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 44 Spain AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 45 Spain AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 46 Denmark AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 47 Denmark AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 48 Denmark AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 49 Denmark AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 50 Sweden AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 51 Sweden AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 52 Sweden AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 53 Sweden AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 54 Norway AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 55 Norway AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 56 Norway AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 57 Norway AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 58 Asia Pacific AI in oncology market, by region, 2018 - 2030 (USD Million)
Table 59 Asia Pacific AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 60 Asia Pacific AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 61 Asia Pacific AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 62 Asia Pacific AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 63 China AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 64 China AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 65 China AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 66 China AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 67 Japan AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 68 Japan AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 69 Japan AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 70 Japan AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 71 India AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 72 India AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 73 India AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 74 India AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 75 South Korea AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 76 South Korea AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 77 South Korea AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 78 South Korea AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 79 Australia AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 80 Australia AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 81 Australia AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 82 Australia AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 83 Thailand AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 84 Thailand AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 85 Thailand AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 86 Thailand AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 87 Latin America AI in oncology market, by region, 2018 - 2030 (USD Million)
Table 88 Latin America AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 89 Latin America AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 90 Latin America AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 91 Latin America AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 92 Brazil AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 93 Brazil AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 94 Brazil AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 95 Brazil AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 96 Mexico AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 97 Mexico AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 98 Mexico AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 99 Mexico AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 100 Argentina AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 101 Argentina AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 103 Argentina AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 104 MEA AI in oncology market, by region, 2018 - 2030 (USD Million)
Table 105 MEA AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 106 MEA AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 107 MEA AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 108 MEA AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 109 South Africa AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 110 South Africa AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 112 South Africa AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 117 UAE AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 118 UAE AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 119 UAE AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 120 UAE AI in oncology market, by end-use, 2018 - 2030 (USD Million)
Table 121 Kuwait AI in oncology market, by component, 2018 - 2030 (USD Million)
Table 122 Kuwait AI in oncology market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait AI in oncology market, by cancer type, 2018 - 2030 (USD Million)
Table 124 Kuwait AI in oncology market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 AI in Oncology Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Commodity flow analysis
Fig. 5 Parent market analysis
Fig. 6 AI in oncology Market snapshot
Fig. 7 AI in oncology Market segment snapshot
Fig. 8 AI in oncology Market segment snapshot
Fig. 9 AI in oncology Market competitive landscape snapshot
Fig. 10 Market research process
Fig. 11 Parent market outlook (USD Billion) (2023)
Fig. 12 AI in oncology market dynamics
Fig. 13 Areas of interest most likely to benefit from AI in the next 10 years
Fig. 14 Anticipated Clinical Impact: Key Areas where AI is Poised to Make a Significant Difference
Fig. 15 Comparison between AI-integrated healthcare and traditional healthcare
Fig. 16 Porter’s Analysis
Fig. 17 PESTEL Analysis
Fig. 18 AI in oncology market, component outlook key takeaways (USD Million)
Fig. 19 AI in oncology market: Component movement analysis, 2023 & 2030 (USD Million)
Fig. 20 Software solutions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Hardware market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 AI in cancer diagnostics market, cancer type outlook key takeaways (USD Million)
Fig. 24 AI in oncology market: Cancer type movement analysis, 2023 & 2030 (USD Million)
Fig. 25 Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Colorectal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Brain tumor market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 AI in cancer diagnostics market, application outlook key takeaways (USD Million)
Fig. 32 AI in oncology market: Application movement analysis, 2023 & 2030 (USD Million)
Fig. 33 Diagnostics (pathology, cancer radiology) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Radiation therapy (Radiotherapy) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Research & development market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 AI in oncology market, end-use outlook key takeaways (USD Million)
Fig. 39 AI in oncology market: End-user movement analysis, 2023 & 2030 (USD Million)
Fig. 40 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Surgical centers and medical institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Regional marketplace: Key takeaways
Fig. 44 AI in Oncology market: Regional outlook, 2023 & 2030 (USD Million)
Fig. 45 AI in Oncology market: Regional outlook, 2023 & 2030 (USD Million)
Fig. 46 North America AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 US AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 US AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Canada AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Europe AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 UK AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Fig.54 Key country dynamics
Fig. 56 Germany AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Fig.56 Key country dynamics
Fig. 58 Spain AI In oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 France AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Italy AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Norway AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Denmark AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Sweden AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Asia Pacific AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Japan AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 China AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 India AI In oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Australia AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 South Korea AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Thailand AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Latin America AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Brazil AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Mexico AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million )
Fig. 87 Key country dynamics
Fig. 88 Argentina AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 MEA AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 South Africa AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Saudi Arabia AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 UAE AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 Kuwait AI in oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key company categorization
Fig. 99 Heat map analysis, 2022 - 2023

Companies Mentioned

  • Azra AI
  • IBM
  • Siemens Healthcare GmbH
  • Intel Corporation
  • GE HealthCare
  • NVIDIA Corporation
  • Digital Diagnostics Inc.
  • ConcertAI
  • Median Technologies
  • PathAI

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedFebruary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 19.17 Billion
Compound Annual Growth Rate28.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Cancer Biopsy Market Size, Share and Trends Analysis Report by Type (Liquid Biopsy, Core Needle Biopsy), Application (Breast Cancer, Lung Cancer), Product (Kits & Consumables, Instruments), and Region 2024-2030 - Product Image

Cancer Biopsy Market Size, Share and Trends Analysis Report by Type (Liquid Biopsy, Core Needle Biopsy), Application (Breast Cancer, Lung Cancer), Product (Kits & Consumables, Instruments), and Region 2024-2030

  • Report
  • 150 Pages
  • Global
From
AI in Oncology For Analytical Solutions Global Market Report 2024 - Product Image

AI in Oncology For Analytical Solutions Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
AI in Oncology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

AI in Oncology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
AI in Cancer Diagnostics Market by Component, Deployment, Cancer Type, End-user - Global Forecast 2025-2030 - Product Image

AI in Cancer Diagnostics Market by Component, Deployment, Cancer Type, End-user - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Artificial Intelligence (AI) in Oncology Market - Forecasts from 2024 to 2029 - Product Image

Artificial Intelligence (AI) in Oncology Market - Forecasts from 2024 to 2029

  • Report
  • 140 Pages
  • Global
From

About the Cancer Diagnostics Artificial Intelligence Market

The Cancer Diagnostics Artificial Intelligence market is a subset of the Artificial Intelligence industry that focuses on the development of AI-based solutions for the diagnosis and treatment of cancer. AI-based solutions are used to analyze medical images, such as CT scans and MRI scans, to detect cancerous cells and tumors. AI-based solutions can also be used to analyze patient data to identify patterns and predict outcomes. AI-based solutions are also used to develop personalized treatments for cancer patients. Companies in the Cancer Diagnostics Artificial Intelligence market include IBM Watson Health, Enlitic, Zebra Medical Vision, and Oncora Medical. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.